Stay updated on Primary Unloading & Delayed Reperfusion in STEMI Clinical Trial

Sign up to get notified when there's something new on the Primary Unloading & Delayed Reperfusion in STEMI Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Primary Unloading & Delayed Reperfusion in STEMI Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.5.4, replacing the previous v3.5.3. This reflects a metadata revision for the study record rather than changes to the study content.
    Difference
    0.0%
    Check dated 2026-05-15T06:14:16.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A Publications section was added to the study record, listing a PubMed-cited article (Kapur et al.) about left ventricular unloading in STEMI (JACC, 2026). The entry notes that publications are auto-filled from PubMed and may not always be about the study.
    Difference
    0.2%
    Check dated 2026-05-01T09:10:14.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page revision indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T06:32:33.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:45:27.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-19T05:33:33.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Updated the Study Outcomes section to add new secondary efficacy and safety endpoints, including ejection fraction (EF) and left ventricular volumes (LVEDV, LVESV, LVEDVi, LVESVi) with multiple time points (3-5 days, 30 days, 90 days, 12 months), and to include percent microvascular obstruction, HF-related hospitalization/urgent care, LVAD or heart transplant, and cardiogenic shock. The previous endpoint infarct size, expressed as a percent of LV mass, and some composite efficacy endpoints were removed or restructuring.
    Difference
    1%
    Check dated 2026-03-11T23:41:08.000Z thumbnail image

Stay in the know with updates to Primary Unloading & Delayed Reperfusion in STEMI Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Primary Unloading & Delayed Reperfusion in STEMI Clinical Trial page.